Themis Medicare Limited (NSE:THEMISMED)
India · Delayed Price · Currency is INR 102.44
+0.86 (0.85%)
Nov 11, 2026, 1:52 PM IST
Themis Medicare Market Cap
Themis Medicare has a market cap or net worth of 9.46 billion as of November 10, 2026. Its market cap has decreased by 14.45% in one year.
Market Cap
9.46B
Enterprise Value
10.37B
Revenue
3.32B
Global Rank
n/a
Country Rank
n/a
PE Ratio
24.42
ChartMarket Cap Chart
Since July 26, 2001, Themis Medicare's market cap has increased from 94.35M to 9.46B, an increase of 9,927.06%. That is a compound annual growth rate of 19.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 9.46B | 2.06% |
| Dec 31, 2025 | 9.27B | -61.73% |
| Dec 31, 2024 | 24.22B | 23.62% |
| Dec 29, 2023 | 19.59B | 58.02% |
| Dec 30, 2022 | 12.40B | 42.22% |
| Dec 31, 2021 | 8.72B | 162.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ind-Swift Laboratories | 30.11B |
| Sakar Healthcare | 21.69B |
| Windlas Biotech | 20.59B |
| Indoco Remedies | 19.85B |
| Beta Drugs | 18.31B |
| Anlon Healthcare | 14.35B |
| Jagsonpal Pharmaceuticals | 14.06B |
| Bafna Pharmaceuticals | 10.75B |